Miyarisan Pharmaceutical Co., Ltd. researches, develops, manufactures and sells products based on its proprietary butyric acid bacterium (Miyairi strain), contributing to human and animal health worldwide. It draws on more than 75 years of expertise in beneficial bacteria.
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen